Zerodha > Trade @ ₹20 (Free Delivery)Know More
Free Account Opening + AMC Free Demat

Aptus Pharma IPO vs Bai Kakaji Polymers IPO

Comparison between Aptus Pharma IPO and Bai Kakaji Polymers IPO.

IPO Details

Aptus Pharma IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Bai Kakaji Polymers IPO is a SME Bookbuilding proposed to list at BSE SME.

 Aptus Pharma IPOBai Kakaji Polymers IPO
LogoAptus Pharma IPO LogoBai Kakaji Polymers IPO Logo
Issue CategorySMESME
Issue TypeIPOIPO
Process TypeBookbuildingBookbuilding
Listing AtBSE SMEBSE SME
Lead ManagersInteractive Financial Services Ltd.Hem Securities Ltd.
RegistrarBigshare Services Pvt.Ltd.Maashitla Securities Pvt.Ltd.
Market Maker
DRHPDRHP DRHP
RHPRHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Aptus Pharma IPO is up to ₹0.00 Cr whereas the issue size of the Bai Kakaji Polymers IPO is up to ₹0.00 Cr. The final issue price of Aptus Pharma IPO is and of Bai Kakaji Polymers IPO is .

 Aptus Pharma IPOBai Kakaji Polymers IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final)
Discount (Retail)
Discount (Employee)
Market Lot Size
Fresh Issue Size20,00,000 shares56,56,000 shares
Fresh Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total20,00,000 shares56,56,000 shares
Issue Size Total (Amount)up to ₹0.00 Crup to ₹0.00 Cr

IPO Timetable

Aptus Pharma IPO opens on , while Bai Kakaji Polymers IPO opens on . The closing date of Aptus Pharma IPO and Bai Kakaji Polymers IPO is , and , respectively.

 Aptus Pharma IPOBai Kakaji Polymers IPO
Anchor Bid Date
Issue Open
Issue Close
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials & KPIs

Aptus Pharma IPO P/E ratio is , as compared to Bai Kakaji Polymers IPO P/E ratio of .

 Aptus Pharma IPOBai Kakaji Polymers IPO
Financials

Aptus Pharma Limited Financial Information (Restated)

Aptus Pharma Limited's revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets21.9210.036.22
Total Income24.6417.8813.90
Profit After Tax3.100.800.19
EBITDA4.761.490.57
Net Worth6.971.770.97
Reserves and Surplus1.971.470.67
Total Borrowing10.365.312.21
Amount in ₹ Crore

Bai Kakaji Polymers Limited Financial Information (Proforma Consolidated)

Period Ended31 Dec 202431 Mar 2024
Assets178.96148.38
Total Income238.05286.33
Profit After Tax13.2611.84
EBITDA31.2827.61
Net Worth50.4837.91
Reserves and Surplus46.4333.16
Total Borrowing104.7084.83
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)100100
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Aptus Pharma IPO Retail Individual Investors (RII) are offered while in Bai Kakaji Polymers IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Aptus Pharma IPO and 0 shares in Bai Kakaji Polymers IPO.

 Aptus Pharma IPOBai Kakaji Polymers IPO
Anchor Investor Reserveration0 shares
Market Maker Reserveration0 shares
QIB0 shares
NII0 shares
RII0 shares
Employee0 shares
Others
Total0 shares

Bids Received (Subscription)

Aptus Pharma IPO subscribed in total, whereas Bai Kakaji Polymers IPO subscribed .

 Aptus Pharma IPOBai Kakaji Polymers IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)